POPULAR- PRESCRIPTION OPTICS PROVIDING A UNIVERSAL LENS FOR AUGMENTED REALITY EYEWEAR

POPULAR aims to develop the first generic Augmented Reality Eyewear (ARE) platform covering the widest range of users and use cases, in professional context, leisure, or daily life. The ordinary-looking glasses will provide visual, wearable, vestibular, and social comfort, making them suitable for all-day use, including personal ophthalmic correction.

Aims

1. Design and Comfort:


  • Create glasses with an ordinary appearance that provide visual, portable, vestibular, and social comfort.

  • Ensure the glasses are suitable for prolonged use throughout the day, including personalized ophthalmic correction.


2. Technological Innovation:

  • Achieve innovations in compactness and invisible technology.

  • Improve the optical quality of the glasses.

  • Minimize energy consumption to extend operating times.

  • Integrate cost-effectiveness aspects into the design and production.


3. Development of Critical Components:

  • Develop an ultra-low-power micro display with related optics and electronics.

  • Create an innovative holographic lens with a mirror.

  • Develop specific application software for the glasses.

  • Integrate all components into functional glasses prototypes.


4. Testing and Demonstration:

  • Conduct final user tests with prototypes in three realistic use scenarios: outdoor sports, healthcare, and logistics.


5. Leadership in the AR Market:

  • Leverage the European industry's opportunity to become a AR market leader.

  • Build on the global leadership of the European eyewear industry and its strong R&D and Innovation capabilities.

  • Develop guidelines that cover user requirements, design, market, and society through project demonstrations.

  • Support the implementation of augmented reality glasses in real-world scenarios.

Collaborating companies

Coordinator:

  • ESSILOR INTERNATIONAL (France)


Partners:

  • MICROOLED SARL (France)

  • INSTITUTO DE BIOMECANICA DE VALENCIA (Spain)

  • UNIVERSITE DE HAUTE ALSACE UHA (France)

  • UNIVERSIDAD DE ALICANTE (Spain)

  • FRAUNHOFER (Germany)

  • TECH2HEAL (France)

  • Fédération Française d'Aviron (France)

  • UNIVERSYTET MEDYCZNY W LODZI.(Poland)

  • Centralny Szpital Kliniczny Uniwersytetu Medycznego (Poland)

  • COMERCIAL ORBEL (Spain)

Duration and reference no.

Start date: 01-01-2024
End date: 31-12-2026
Project reference no.: GA-101135770 HORIZON-CL4-2023-HUMAN-01-CNECT

𝘛𝘩𝘪𝘴 𝘱𝘳𝘰𝘫𝘦𝘤𝘵 𝘩𝘢𝘴 𝘳𝘦𝘤𝘦𝘪𝘷𝘦𝘥 𝘧𝘶𝘯𝘥𝘪𝘯𝘨 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘌𝘶𝘳𝘰𝘱𝘦𝘢𝘯 𝘜𝘯𝘪𝘰𝘯’𝘴 𝘏𝘰𝘳𝘪𝘻𝘰𝘯 𝘌𝘶𝘳𝘰𝘱𝘦 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘱𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘦 𝘶𝘯𝘥𝘦𝘳 𝘨𝘳𝘢𝘯𝘵 𝘢𝘨𝘳𝘦𝘦𝘮𝘦𝘯𝘵 𝘕𝘰101135770.